Global Cord Blood Corporation
CO was delisted on the 23rd of September, 2022.
2 hedge funds and large institutions have $13.7K invested in Global Cord Blood Corporation in 2025 Q3 according to their latest regulatory filings, with funds opening new positions, increasing their positions, 1 reducing their positions, and closing their positions.
0% more funds holding
Funds holding: 2 → 2 (0)
64% less capital invested
Capital invested by funds: $37.5K → $13.7K (-$23.8K)
100% less repeat investments, than reductions
Existing positions increased: 0 | Existing positions reduced: 1
Top Buyers
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
RhumbLine Advisers
Boston,
Massachusetts
|
-$11.6K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
1
RhumbLine Advisers
Boston,
Massachusetts
| $13.5K | -$11.6K | -11,455 | -46% |
|
|
LC
2
Luminist Capital
Grand Rapids,
Michigan
| $165 | – | – | – |
|
CO Hedge Fund Activity: Q3 2025 in Review
2 of the 7,619 institutional investors tracked by Wall St. Rank reported a position in Global Cord Blood Corporation (CO) for Q3 2025, worth a combined $13.7K — down 64% from $37.5K a quarter earlier.
Fund positioning in CO was balanced in Q3 2025: 0 funds opened new positions, 0 closed out, 0 added to existing stakes and 1 trimmed.
The largest seller was RhumbLine Advisers, cutting an estimated $11.6K.
- 2 institutional investors held Global Cord Blood Corporation (CO) as of Q3 2025, unchanged from Q2 2025.
- Funds reported $13.7K of Global Cord Blood Corporation stock for Q3 2025, down 64% quarter-over-quarter.
- 0 funds opened new Global Cord Blood Corporation positions in Q3 2025 and 0 closed out.
- The largest Global Cord Blood Corporation seller in Q3 2025 was RhumbLine Advisers, an estimated $11.6K sold.
Based on aggregated 13F filings for Q3 2025.